Patents Assigned to BETA INNOV
  • Pharmaceutical compositions containing beta-2 microglobulin and methods of treating autoimmune diseases
    Patent number: 11484571
    Abstract: A pharmaceutical product containing ?2-microglobulin or a functional variant thereof as an active ingredient in the form of liposomes is provided. The product can increase the concentration of ?2-microglobulin in the blood, and can also restore a normal HC/?2-microglobulin molar ratio within membrane MHC-I complexes, or prevent a ?2-microglobulin deficit from occurring in the MHC-I complexes, of patients suffering from autoimmune diseases. Methods of treating patients with the pharmaceutical product are also presented.
    Type: Grant
    Filed: October 20, 2016
    Date of Patent: November 1, 2022
    Assignee: BETA INNOV
    Inventors: Marcel Mersel, Clovis Rakotoarivelo
  • Sterol derivatives and use thereof for treating diseases involving transformed astrocyte cells or for treating malignant haemopathies
    Patent number: 10800806
    Abstract: Novel sterol derivatives, the preparation method thereof, pharmaceutical compositions containing them and use thereof for treating diseases involving transformed astrocyte cells or for treating malignant haemopathies. The treatment of glioblastoma multiforme, as well as of other cancers, such as lymphomas, neuroblastomas and melanomas is also described.
    Type: Grant
    Filed: May 7, 2013
    Date of Patent: October 13, 2020
    Assignee: BETA INNOV
    Inventors: Ludovic Clarion, Marcel Mersel, Didier Petite
  • STEROL DERIVATIVES AND USE THEREOF FOR TREATING DISEASES INVOLVING TRANSFORMED ASTROCYTE CELLS OR FOR TREATING MALIGNANT HAEMOPATHIES
    Publication number: 20150086615
    Abstract: Novel sterol derivatives, the preparation method thereof, pharmaceutical compositions containing them and use thereof for treating diseases involving transformed astrocyte cells or for treating malignant haemopathies. The treatment of glioblastoma multiforme, as well as of other cancers, such as lymphomas, neuroblastomas and melanomas is also described.
    Type: Application
    Filed: May 7, 2013
    Publication date: March 26, 2015
    Applicant: BETA INNOV
    Inventors: Ludovic Clarion, Marcel Mersel, Didier Petite
  • THERAPEUTIC USE OF THE ß2m PROTEIN
    Publication number: 20130017212
    Abstract: The use of beta2-microglobulin (?2m) as active ingredient, in particular in pharmaceutical compositions intended for the treatment of autoimmune diseases.
    Type: Application
    Filed: April 6, 2011
    Publication date: January 17, 2013
    Applicant: BETA INNOV
    Inventors: Marcel Mersel, Clovis Rakotoarivelo